Wednesday 21 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 1 month ago

Novartis drug cut death risk by 35 percent in gene mutation breast cancer

An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation.

Related news

Latest News
Hashtags:   

Novartis

 | 

death

 | 

percent

 | 

mutation

 | 

breast

 | 

cancer

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources